Information
-
Trademark
-
79175768
-
Serial Number
79175768
-
Registration Number
5126200
-
International Classifications
-
Filing Date
December 29, 2014
10 years ago
-
Registration Date
January 24, 2017
8 years ago
-
Transaction Date
May 07, 2024
10 months ago
-
Status Date
August 04, 2023
a year ago
-
Published for Opposition Date
November 08, 2016
8 years ago
-
Location Date
January 24, 2017
8 years ago
-
Status Code
709
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
THOMAS, JULIE
-
Attorney Docket Number
36381-0020US
Attorney Name
Elizabeth Brenckman
Law Office Assigned Location Code
L70
-
Owners
Mark Drawing Code
3
Mark Identification
D DOMPÉ
Case File Statements
- GS0411: Entertainment television news programme services in the field of pharmaceutical products and sanitary preparations for medical purposes broadcast over the internet; organizing community festivals featuring primarily pharmaceutical exhibition for medical purposes; arranging professional workshop and training courses in the field of pharmaceutical products and medicine for medical purposes; training services in the field of pharmaceutical and sanitary preparations for medical purposes; education service, namely, providing tutoring in the field of pharmaceutical and sanitary preparations for medical purposes; providing information relating to organizing community cultural activities and contests
- DM0000: The mark consists of a hexagon with a letter "D" in the center and the wording "DOMPÉ" to the right of the design.
- GS0051: Pharmaceutical preparation for the treatment of respiratory diseases; pharmaceutical preparation for the treatment of bone diseases; analgesic and muscle relaxant pharmaceutical preparations; antibacterial pharmaceuticals; anti-epileptic pharmaceutical preparations; balms for pharmaceutical purposes; capsules sold empty for pharmaceuticals; cardiovascular pharmaceuticals; gelatin capsules sold empty for pharmaceuticals; ocular pharmaceuticals; pharmaceutical products for ophthalmological use; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases also rare; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases; pharmaceutical antitussive cold pharmaceutical preparations for use in chemotherapy; pharmaceutical products for the treatment of viral and infectious diseases; pharmaceutical products for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in tissue and organ transplantation also rare; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for treating diabetes also rare; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of bacteria-based diseases, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; sanitary preparations for medical purposes; all-purpose disinfectants
- PM0001: DOMPÉ DOMPÉ
- CC0000: Color is not claimed as a feature of the mark.
- GS0421: Conducting early evaluations in the field of new pharmaceuticals; conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology, treatment of cancer, diabetes, analgesic preparations, nerve grow factors, oncology, organ transplantation, antibiotics, respiratory diseases, bone diseases, rare diseases; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, medical diagnostics, drug development and pharmacogenetics; development of pharmaceutical preparations and medicines; laboratory research services relating to pharmaceuticals; research and development of pharmaceuticals for the treatment of cancer, diabetes, respiratory diseases, bone diseases, rare diseases, ocular disorders and diseases; research and development in the pharmaceutical and biotechnology fields
Case File Event Statements
-
11/12/2015 - 9 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/7/2015 - 9 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IB
Type: REPR
-
11/10/2015 - 9 years ago
2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED
Type: LIMI
-
11/12/2015 - 9 years ago
3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
11/17/2015 - 9 years ago
5 - APPLICATION FILING RECEIPT MAILED
Type: MAFR
-
6/1/2016 - 8 years ago
14 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
11/19/2015 - 9 years ago
6 - ASSIGNED TO EXAMINER
Type: DOCK
-
11/25/2015 - 9 years ago
7 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
11/26/2015 - 9 years ago
8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Type: RFCR
-
12/1/2015 - 9 years ago
9 - REFUSAL PROCESSED BY MPU
Type: RFRR
-
12/1/2015 - 9 years ago
10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Type: RFCS
-
12/18/2015 - 9 years ago
11 - REFUSAL PROCESSED BY IB
Type: RFNT
-
4/28/2016 - 8 years ago
12 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
6/1/2016 - 8 years ago
13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
9/28/2016 - 8 years ago
19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED
Type: ERFR
-
9/28/2016 - 8 years ago
22 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
10/19/2016 - 8 years ago
23 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
10/19/2016 - 8 years ago
24 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Type: OP2R
-
10/19/2016 - 8 years ago
25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Type: OPNS
-
6/2/2016 - 8 years ago
15 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
6/30/2016 - 8 years ago
16 - FINAL REFUSAL WRITTEN
Type: CNFR
-
6/30/2016 - 8 years ago
17 - FINAL REFUSAL E-MAILED
Type: GNFR
-
6/30/2016 - 8 years ago
18 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
9/28/2016 - 8 years ago
20 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
9/28/2016 - 8 years ago
21 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
11/8/2016 - 8 years ago
27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
1/24/2017 - 8 years ago
29 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
4/24/2017 - 7 years ago
30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Type: FICR
-
2/12/2021 - 4 years ago
34 - NEW REPRESENTATIVE AT IB RECEIVED
Type: NREP
-
11/8/2016 - 8 years ago
26 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
11/18/2016 - 8 years ago
28 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Type: OPNX
-
4/26/2017 - 7 years ago
31 - FINAL DISPOSITION PROCESSED
Type: FIMP
-
4/26/2017 - 7 years ago
32 - FINAL DISPOSITION NOTICE SENT TO IB
Type: FICS
-
5/20/2017 - 7 years ago
33 - FINAL DECISION TRANSACTION PROCESSED BY IB
Type: FINO
-
1/24/2022 - 3 years ago
36 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Type: REM3
-
8/4/2023 - a year ago
37 - CANCELLED SECTION 71
Type: C71T
-
4/4/2024 - 11 months ago
38 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Type: INTR
-
4/13/2024 - 10 months ago
40 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Type: INTS
-
5/6/2024 - 10 months ago
41 - TOTAL INVALIDATION PROCESSED BY THE IB
Type: INNT
-
4/13/2024 - 10 months ago
39 - INVALIDATION PROCESSED
Type: INPC
-
6/4/2021 - 3 years ago
35 - CHANGE OF NAME/ADDRESS REC'D FROM IB
Type: ADCH